Skip to search formSkip to main contentSkip to account menu

Fumarylacetoacetase

Known as: fumarylacetoacetate fumarylhydrolase, fumarylacetoacetate hydrolase 
National Institutes of Health

Related topics

Related topics

4 relations
FAH geneFAHD1 gene

Broader (1)

Hydrolase

Narrower (1)

fahA protein, Emericella nidulans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
TRANSCERVICAL EXTENDED MEDIASTINAL LYMPHADENECTOMY ( TEMLA ) : SINGLE-CENTER EXPERIENCE AND NOVEL CLINICAL APPLICATIONS
1 | Cardiothoracic | Clinical Science TRANSCERVICAL EXTENDED MEDIASTINAL LYMPHADENECTOMY (TEMLA): SINGLECENTER EXPERIENCE AND… 
Review
2017
Review
2017
A Review of Metabolic Disorder of Amino Acid Tyrosinemia type I: When to Suspect and how to Diagnose
Background: Hereditary Tyrosinemia I (HT1) is an inborn error of tyrosine catabolism; an autosomal recessive disorder caused by… 
2015
2015
Clinical and Biochemical Profile of Tyrosinemia Type 1 in Tunisia.
BACKGROUND Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disease caused by a defect of fumarylacetoacetate… 
2014
2014
Neuroscience: A large-scale approach to correlate neurons and behavior
gene correction with crispr in adult mice The clustered, regularly interspaced, short palindromic repeats (CRiSPR)-Cas9 system… 
2004
2004
Tyrosinämie Typ I
ZusammenfassungDie Tyrosinämie Typ I ist ein autosomal-rezessiv vererbter Defekt des Tyrosinstoffwechsels. Sie beruht auf einem… 
Review
2003
Review
2003
[Hereditary tyrosinemia: an endoplasmic reticulum stress disorder?].
Hereditary tyrosinemia type 1 (HT1) is the most severe metabolic disease associated with tyrosine catabolism. An accumulation of… 
2000
2000
Tyrosinämie Typ I Klinische und biochemische Symptome bei 3 Säuglingen
ZusammenfassungHintergrund. Die Tyrosinämie Typ I ist durch einen autosomal-rezessiv vererbten Defekt der… 
1993
1993
TYROSINEMIA TYPE I. RESOLUTION OF THE METABOLIC ABNORMALITIES AND INCREASED GROWTH FOLLOWING LIVER TRANSPLANTATION.
Type I tyrosinemia is a lack of fumarylacetoacetate hydrolyase (FAA), with accumulation of abnormal metabolites of tyrosine that… 
1986
1986
Purification of mRNA coding for the enzyme deficient in hereditary tyrosinemia, fumarylacetoacetate hydrolase.
As a step towards the cloning of the gene for fumarylacetoacetate hydrolase (FAH), we have purified the FAH mRNA from rat liver… 
1973
1973
Inhibition of fumarylacetoacetate fumarylhydrolase by monovalent anions.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)